연구동향 분석

원저 : 낙석등 추출물이 토끼 HIG-82 활액막 세포주에서 Sodium Nitroprusside (SNP)로 유도된 염증반응에 미치는 영향

박정식 ( Jung Sik Park ) 임형호 ( Hyung Ho Lim ) 2014년

논문상세정보
인용/피인용
' 원저 : 낙석등 추출물이 토끼 HIG-82 활액막 세포주에서 Sodium Nitroprusside (SNP)로 유도된 염증반응에 미치는 영향' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 한의학(韓醫學, 漢醫學)
  • cox-2
  • inflammation
  • inos
  • no
  • pge2
  • tnf-α
  • trachelospermumcaulis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,287 0

0.0%

' 원저 : 낙석등 추출물이 토끼 HIG-82 활액막 세포주에서 Sodium Nitroprusside (SNP)로 유도된 염증반응에 미치는 영향' 의 참고문헌

  • 팥 에탄올 추출물의 Papain 유도 관절염 마우스에서의 항 골관절염 효과
    정시화 동의생리병리학회지 26 (5) : 665 ~ 671 [2012]
  • 생리학
    William F 한우리 : 681 ~ [1999]
  • 본초학
  • 絡石藤의 效能에 關한 實驗的 硏究
    임형호 경희의학 7 (3) : 334 ~ 341 [1991]
  • 絡石藤약침이 Collagen 유발 관절염에 미치는 영향
    이태호 대한침구의학회지 26 (6) : 51 ~ 65 [2009]
  • 絡石藤과 地錦의 效能에 關한 書誌學的 比較考察
    신민교 대한본초학회지 13 (1) : 37 ~ 43 [1988]
  • Upregulation of nitric oxide synthase in cultured human keratinocytes after ultraviolet B and bradykinin
    Kang-Rotondo CH Photodermatol Photoi mMunol Photomed 12 (2) : 57 ~ 65 [1996]
  • Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor(p75)-Fc fusion protein
    Moreland LW N Engl J Med 337 (3) : 141 ~ 147 [1997]
  • Time course of expression of mRNA of inducible nitric oxide synthase and generation of nitric oxide by ultraviolet B in keratinocyte cell lines
    Seo SJ Br J Dermatol 147 (4) : 655 ~ 662 [2002]
  • The mechanisms of action of NSAIDs in analgesia
    Cashman JN Drugs 52 (5) : 13 ~ 23 [1996]
  • The antiinfla mMatory and antiviral effects of hydroxychloroquine in two patients with acquired i mMunodeficiency syndrome and active infla mMatory arthritis
    Matthew H Ornstein Arthritis Rheum 39 (1) : 157 ~ 161 [1996]
  • Suppression of arthritis by an inhibitor of nitric oxide synthase
    McCartney-Francis N J Exp Med 178 (2) : 749 ~ 754 [1993]
  • Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7macrophages
    Kim KW Vascul Pharmacol 47 (2,3) : 99 ~ 107 [2007]
  • Osteoarthritis;an overview of the disease and its treatment strategies
    Sarzi-Puttini P Semin Arthritis Rheum 35 (1) : 1 ~ 10 [2005]
  • Nitric oxide synthases: Roles, tolls and controls
    Nathan C Cell 78 (6) : 915 ~ 918 [1994]
  • Nitric oxide synthase : expression and expressional control of the three isoforms
    Förstermann, U Naunyn Schmiedebergs Arch Pharmacol 352 (4) : 351 ~ 364 [1995]
  • Nitric oxide and macrophage function
    MacMicking J Annu Rev I mMunol 15 : 323 ~ 350 [1997]
  • Nitric oxide : mediator, murderer, and medicine
    Anggård E Lancet 343 (8907) : 1199 ~ 1206 [1994]
  • Nitric oxide : cellular regulation and neuronal injury
    Dawson TM Prog Brain Res 103 : 365 ~ 369 [1994]
  • New drugs for rheumatoid arthritis
    Olsen NJ N Engl J Med 350 (21) : 2167 ~ 2179 [2004]
  • NADPH-diaphorase-positive nerves and the role of nitric oxide in CGRP relaxation of uterine contraction
    Shew RL Peptides 14 (3) : 637 ~ 641 [1993]
  • Inhibition of interleukin-1 induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine
    Badger AM J Pharmacol Exp Ther 290 (2) : 587 ~ 593 [1999]
  • In-vitro and in-vivo anti-infla mMatory action of the ethanol extract of Trachelospermi caulis
    Lee MH J Pharm Pharmacol 59 (1) : 123 ~ 130 [2007]
  • IL-6 : a regulator of the transition from neutrophil to monocyte recruitment during infla mMation
    Kaplanski G Trends I mMunol 24 (1) : 25 ~ 29 [2003]
  • HARRISON'S 내과학
    Kasper, Braunwald 도서출판 MIP : 2148 ~ 2151 [2006]
  • Genistein-4'-O-α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside의RAW 264.7 세포에서 NF-κB 불활성화를 통한 LPS에 의해 유도되는iNOS, COX-2 그리고 cytokine들의 발현 저해효과
    이경태 생약학회지 38 (4) : 339 ~ 348 [2007]
  • Enhanced expression of inducible nitric oxide synthase by Juzen-taiho-to in LPS activated RAW 264.7 cells, a murine macrophage cell line
    Kawamata H Am J Chin Med 28 (2) : 217 ~ 226 [2000]
  • Detection of tumor necrosis factor a but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
    Saxne T Arthritis Rheum 31 (8) : 1041 ~ 1045 [1988]
  • Cytokines in osteoarthritis : mediators or makers of joint destruction
    Westacott CI Semin Arthriris Rheum 25 (4) : 254 ~ 327 [1996]
  • Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy
    Barrera P Arthritis Rheum 36 (8) : 1070 ~ 1079 [1993]
  • Chronic infections and infla mMatory processes as cancer risk factors : possible role of nitric oxide in carcinogenesis
    Ohshima H Mutat Res 305 (2) : 253 ~ 264 [1994]
  • Chemical constituents of Trachelospermum jasminoides
    Tan XQ Nat Prod Res 24 (13) : 1248 ~ 1252 [2010]
  • Both tumor necrosis factor and nitric oxide participate in lysis of simian virus40-transformed cells by activated macrophages
    Duerksen-Hughes PJ J I mMunol 149 (6) : 2114 ~ 2122 [1992]
  • Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
    Crofford LJ Arthritis Rheum 43 (1) : 4 ~ 13 [2000]
  • Anakinra : A recombinant human interleukin-1 receptor antagonist(rmetHulL-1ra), in patients with rheumatoid arthritis : A large, international, multicenter, placebo-controlled trial
    Fleischmann RM Arthritis Rheum 48 (4) : 927 ~ 934 [2003]
  • Alterations in nitric oxide production in various forms of circulatory shock
    Szabó C New Horiz 3 (1) : 2 ~ 32 [1995]
  • A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-α antibody adalimumab(D2E7)in patients with rheumatoid arthritis
    Den Broeder A J Rheumatol 29 (11) : 2288 ~ 2298 [2002]
  • 2011 국민건강통계
    보건복지부 건강정책과 보건복지부 : 512 ~ [2012]